SUI Group Holdings Limited (NASDAQ: SUIG) ("SUI Group" or the "Company"), today announced it has co-led with Karatage Opportunities a $15 million funding round for Nof1, a world-class AI research lab ...
Ex-Meta and DeepMind researchers raised $650m at a $4.65bn valuation for Recursive Superintelligence, a startup betting AI ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched ...
Brand-new startups are continuing to raise massive rounds to work on new niches of AI. Recursive, a stealth-mode AI lab, has emerged ...
A London-based AI startup set up just months ago, which believes it’s pursuing the fastest path to surpassing human ...
BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law ...
Robotics gap closed: UK researchers developed a method to transfer robot skills from simulation to reality using minimal real-world data, reducing cost and risk. Networks learn continuously: ...
What is RSI?: Recursive self-improvement refers to AI systems enhancing their own capabilities, potentially accelerating innovation beyond human pace. Recent breakthroughs: Firms like OpenAI and ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...
Penn researchers have developed a smarter AI method for solving notoriously difficult inverse equations, which help ...
ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results